https://ir.dermapharm.de/en/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/contact-us/ 2026-02-19T12:51:43+00:00 0.5 https://ir.dermapharm.de/en/corporate-news/dermapharm-successfully-acquires-c3-group/ 2023-07-14T09:48:35+00:00 0.5 https://ir.dermapharm.de/en/imprint/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/data-protection/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/terms-conditions/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/share/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/financial-figures/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/financial-calendar/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/financial-news/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/financial-reports-presentations/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/factsheet/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/sustainability/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/annual-general-meeting/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/investor-relations/mandatory-publications/ 2025-12-01T08:23:22+00:00 0.5 https://ir.dermapharm.de/en/company/ 2025-12-01T08:23:22+00:00 0.5